1. Home
  2. BYND vs AKBA Comparison

BYND vs AKBA Comparison

Compare BYND & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYND
  • AKBA
  • Stock Information
  • Founded
  • BYND 2009
  • AKBA 2007
  • Country
  • BYND United States
  • AKBA United States
  • Employees
  • BYND N/A
  • AKBA N/A
  • Industry
  • BYND Packaged Foods
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BYND Consumer Staples
  • AKBA Health Care
  • Exchange
  • BYND Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • BYND 416.9M
  • AKBA 336.2M
  • IPO Year
  • BYND 2019
  • AKBA 2014
  • Fundamental
  • Price
  • BYND $5.01
  • AKBA $1.82
  • Analyst Decision
  • BYND Sell
  • AKBA Strong Buy
  • Analyst Count
  • BYND 6
  • AKBA 2
  • Target Price
  • BYND $5.50
  • AKBA $5.75
  • AVG Volume (30 Days)
  • BYND 3.2M
  • AKBA 2.4M
  • Earning Date
  • BYND 11-06-2024
  • AKBA 11-07-2024
  • Dividend Yield
  • BYND N/A
  • AKBA N/A
  • EPS Growth
  • BYND N/A
  • AKBA N/A
  • EPS
  • BYND N/A
  • AKBA N/A
  • Revenue
  • BYND $323,473,000.00
  • AKBA $169,879,000.00
  • Revenue This Year
  • BYND N/A
  • AKBA N/A
  • Revenue Next Year
  • BYND $3.41
  • AKBA $6.13
  • P/E Ratio
  • BYND N/A
  • AKBA N/A
  • Revenue Growth
  • BYND N/A
  • AKBA N/A
  • 52 Week Low
  • BYND $4.79
  • AKBA $0.80
  • 52 Week High
  • BYND $12.12
  • AKBA $2.48
  • Technical
  • Relative Strength Index (RSI)
  • BYND 36.24
  • AKBA 56.59
  • Support Level
  • BYND $4.79
  • AKBA $1.76
  • Resistance Level
  • BYND $5.23
  • AKBA $2.02
  • Average True Range (ATR)
  • BYND 0.33
  • AKBA 0.11
  • MACD
  • BYND -0.06
  • AKBA -0.02
  • Stochastic Oscillator
  • BYND 12.15
  • AKBA 40.00

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels, and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor, is approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: